Report Scope: This report provides an elaborate summary of the market, including a market snapshot and company profiles of key players competing in the microbiome sequencing market.It provides an exhaustive segmentation of the market with in-depth information about each segment.
The overview section of the report provides a source of description of market trends and market dynamics, which includes drivers, limitations, challenges and opportunities in the market.It provides information about market development and future trends that can be useful for organizations, including wholesalers and exporters.
It provides market positioning of key players using the yardsticks of revenue, product portfolio and recent activities.It includes strategies adopted by emerging market players with strategic recommendations for new market entrants.
Outright information is provided in the report, consisting of historic and current market size and including the future potential of the market. The report will enable market players and new entrants to make an informed decision about the production and export of goods and services to the original equipment manufacturer.
The market is segmented on the basis of sequencing technology, component, applications, laboratory type and end use.Geographic market analysis is provided for all major segments.
The report offers country level analysis of the market to provide better understanding of major segments.
Report Includes: - 60 data tables and 17 additional tables - An overview of the global market and technologies for genome sequencing within the industry - Analyses of global market size and trends, with data from 2017, 2018 and projections of CAGRs through 2023 - Key outline of present and future market potentials, and factors influencing the microbiome sequencing market - Discussion on impact of genome sequencing on pharmaceutical, biotechnology and healthcare sectors - Information on automated instruments and discussion on how it facilitates speedy sequencing procedures - Insights into government initiatives and funding for the development of effective drugs for the treatment and prevention from chronic diseases - Company profiles of the major players of the market, including Biolog Inc., CosmosID Inc., Illumina Inc., Metabiomics and Oxford Nanopore Technologies Ltd.
Summary Researchers from around the globe find significant potential in microbiome study to explore gut-related, metabolic, inflammatory, auto-immune diseases, neurological conditions and more.Microbiome sequencing is one key process used in analysis of human microbiomes.
Innovative sequencing technologies such as NGS and Third-generation Sequencing generate data on the human microbiome.Novel High-throughput Sequencing via hardware and software tools are revolutionizing microbiome sequencing.
These technologies enable the delivery of services at high speed, with good quality and at an attractive cost. The global microbiome sequencing market is expected to witness significant growth, at a CAGR of REDACTED during the forecast period (2018-2023). The market value of the global microbiome sequencing market was REDACTED in 2017 and is projected to reach over REDACTED in 2023. Growthin the market is attributed to the rising focus on human microbiome therapy, increasing government initiatives, plentiful funding for microbiome research and growing research programs for early diseasediagnosis.
The microbiome sequencing market is driven by numerous factors including increasing emphasis on microbiome sequencing for early detection and diagnosis.Many market players are engaging in collaborative AI (Artificial Intelligence) for microbiome sequencing to promote studies on gut microbiomes.
In 2018, Viome Inc. developed Vie’s AI system. The system uses data gathered from four sources: biological testing, expert knowledge, customer feedback and scientific literature. Increased government spending for the promotion of microbiome research is expected to promote the growth of the global market in the future. One such initiative is the Human Microbiome Project (HMP), which began in 2007 as an extension of the Human Genome Project. The project, put forth by the NIH, was initiated to enhance research on microbiomes in the U.S. The cost associated with sequencing technologies has decreased over the past few years.
Microbiome sequencing technology has numerous applications. Companies such as Metagenom Bio Inc. and Resphera Biosciences LLC provide microbiome products and services in various sectors: agriculture, mining, computational and bioproducts. Since microbiome sequencing is a new technology, a lack of skilled labor is one factor expected to have a negative impact on the growth of the market.
The global microbiome sequencing market has been segmented on the basis of sequencing technology, components, applications, end users and laboratory types.The global microbiome sequencing market has been segmented into technologies: Sanger Sequencing,High-throughput Sequencing and Thirdgeneration Sequencing.
Sanger Sequencing is the dominant technology in the microbiome sequencing market, valued at REDACTED in 2017.That market segment is projected to reach REDACTED in 2023 growing at a CAGR of REDACTED during the forecast period.
Sanger Sequencing is preferred by biologists andresearchers due to its accuracy. It offers new perspectives for genome analysis and exploration and is based on the chain termination method.
Our reports have been used by over 10K customers, including:
Global Population Sequencing Market to Reach $64,047.6 Million by 2030 Market Report Coverage - Global Population Sequencing Market Market Segmentation • Product Type – Kits and Assays, Platforms, Software Tools • Application- Human Health, Molecular Forensics, Blockchain...
Genotyping Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Genotyping market including the COVID-19 pandemic implications for Genotypings industry.The...
Single Cell Genome Sequencing Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Single Cell Genome Sequencing market including the COVID-19 pandemic...
The Europe digital genome market is expected to reach US$ 5,994.09 million by 2027 from US$ 3,250.04 million in 2019. The market is estimated to grow at a CAGR of 8.1% during 2020-2027. The digital genome market is growing primarily due to the increasing prevalence of chronic diseases and growing funding for genomics in the Europe region....
The North America digital genome market is expected to reach US$ 9,594.71 million by 2027 from US$ 4,999.94 million in 2019. The market is estimated to grow at a CAGR of 8.7% during 2020-2027. The digital genome market is growing primarily due to the increasing prevalence of chronic diseases and growing funding for genomics in the North America...
Microbiome Sequencing Services Market Research Report by Technology (Pyro sequencing, RNA Sequencing, Sanger Sequencing, Sequencing by Ligation (SBL), and Sequencing by Synthesis (SBS)), by End User (Pharmaceutical and Biotechnology Companies and Research and Academic Institutes), by Application - Global Forecast to 2025 - Cumulative...
154 pages •
By Global Industry Analysts
• Jul 2020
Global Genotyping Market to Reach $46.4 Billion by 2027 Amid the COVID-19 crisis, the global market for Genotyping estimated at US$13.9 Billion in the year 2020, is projected to reach a revised size of US$46.4 Billion by 2027, growing at a CAGR of 18.7% over the analysis period 2020-2027. Polymerase Chain Reaction (PCR), one of the...
Global DNA Methylation Market to Reach $8.88 Billion by 2030 Market Report Coverage - DNA Methylation Market Segmentation • By Product: Consumables, Instruments, and Software • By Technology: Polymerase Chain Reaction (PCR), Sequencing, Microarray, and others. • By Application: Clinical...
192 pages •
By Global Industry Analysts
• Sep 2020
Global DNA Sequencing Market to Reach $28.8 Billion by 2027 Amid the COVID-19 crisis, the global market for DNA Sequencing estimated at US$9.4 Billion in the year 2020, is projected to reach a revised size of US$28.8 Billion by 2027, growing at a CAGR of 17.3% over the analysis period 2020-2027. Diagnostics, one of the segments analyzed...
The Asia Pacific digital genome market is expected to reach US$ 4,118.86 million by 2027 from US$ 2,077.27 million in 2019. The market is estimated to grow at a CAGR of 9.1% during 2020-2027. The digital genome market is growing primarily due to the increasing prevalence of chronic diseases and growing funding for genomics in the Asia Pacific...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.